You are here

  • Home
  • Archive
  • Volume 5, Issue 2
  • Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible

Article metrics

Article menu

Download PDFPDF

Psoriatic arthritis
Original article
Patients with psoriatic arthritis who are not eligible for randomised controlled trials for TNF inhibitors have treatment response and drug survival similar to those who are eligible

 

Online download statistics by month:

Online download statistics by month: July 2019 to March 2024

AbstractFullPdf
Jul 2019828117
Aug 2019595826
Sep 2019636241
Oct 2019434125
Nov 2019343425
Dec 2019313115
Jan 2020222112
Feb 202029294
Mar 202025248
Apr 202013138
May 2020232318
Jun 2020552
Jul 2020222227
Aug 2020111010
Sep 2020272111
Oct 202018166
Nov 202012129
Dec 2020111011
Jan 2021151313
Feb 2021151511
Mar 2021262519
Apr 2021191913
May 202118174
Jun 202118188
Jul 202116163
Aug 202119178
Sep 2021272617
Oct 2021252521
Nov 2021131312
Dec 202115151
Jan 202212122
Feb 202219205
Mar 202236279
Apr 202215154
May 2022333310
Jun 202223214
Jul 202216163
Aug 2022383817
Sep 2022293021
Oct 202229284
Nov 2022515110
Dec 2022151710
Jan 202312125
Feb 202342427
Mar 202318198
Apr 202314145
May 202314149
Jun 2023993
Jul 2023191912
Aug 20239910
Sep 202319187
Oct 2023232311
Nov 202343434
Dec 202357575
Jan 202415156
Feb 202415158
Mar 2024222211
Total14031371615